How Much Does Medical Cannabis Cost in Israel?

For most Israeli patients, medical cannabis is paid for out of pocket — and the total bill is more than just the product. Between the specialist consultation, the licence, the prescription and the cannabis itself, costs can add up in ways that surprise first-time patients. This guide breaks down each component, explains why prices vary so much between pharmacies, and gives a realistic monthly budget.

This guide is informational and is not medical or financial advice. Prices change frequently; confirm current figures with your HMO and dispensing pharmacy.

Why cannabis costs more than a normal prescription

The single most important fact about cannabis pricing in Israel is that it sits outside the national health basket (sal habriut). Standard subsidised medicines are heavily discounted by the state; cannabis is not, so patients carry most of the cost themselves (Leumit Health Services). That one structural difference explains why a treatment that is "approved" by the Ministry of Health can still be expensive.

The cost breaks into a few distinct pieces: the medical examination and consultation, the licence or prescription fee, and the product itself at the pharmacy. Each is billed separately, and only the last varies with how much cannabis you actually use.

The licence and HMO charges

Patients typically pay deductible-style charges through their health fund (HMO) for the parts of the process the fund administers — the specialist examination, the issuing of the permit, and the prescription. The licence itself carries a recurring fee in the region of ₪300 per year (Yad LaOlim). On top of that, a private specialist consultation — often the fastest route to a recommendation — can add a one-off fee, since not every patient can reach an in-network specialist who prescribes cannabis quickly.

These administrative charges are modest next to the product cost, but they recur. Because licences must be renewed and, since the 2024 reform, renewals beyond six months can require a fresh physician meeting, patients should budget for the paperwork as an ongoing cost rather than a one-time entry fee. For background on the application itself, see our guide on how to get a medical cannabis licence in Israel.

The product: from a fixed price to a market

The way patients pay for the cannabis itself changed fundamentally in 2019. Before then, the out-of-pocket price was regulated and flat: patients paid a fixed ₪370 per month (about $100) for their supply regardless of quantity, with product distributed directly by growers (Journal of Cannabis Research, 2025).

In May 2019 the Ministry scrapped that model in favour of a market-based, per-product system sold through pharmacies. When the reform took effect, pharmacy prices ran roughly ₪15–39 per gram — meaning a 30-gram monthly licence cost somewhere between about ₪450 and ₪1,170 depending on the product chosen (Journal of Cannabis Research, 2025). The government's committee assumed that for most patients, whose monthly allowance was 30 grams or less, the change would leave costs broadly similar or even lower. In practice, many patients found the opposite: when chain pharmacies entered the market, some products were priced higher per gram than under the old flat rate — early Super-Pharm listings, for example, ran ₪120–140 per 10 grams (Globes).

What you'll actually pay per month

Because pharmacies now set their own prices and discounts, the honest answer to "what does it cost?" is: it depends on your dosage, your product and your pharmacy. As a rough guide, legal pharmacy flower commonly runs in the range of ₪100–350 per 10 grams (Yad LaOlim). A typical monthly bill for the cannabis alone can reach up to around ₪800 for many patients, depending on the prescribed quantity (Yad LaOlim).

To estimate your own cost, work from your licensed monthly quantity (in grams) and the per-gram price of the specific product your pharmacist recommends. A patient on a 20-gram monthly licence buying a mid-range flower will pay very differently from one on a 50-gram licence using a premium oil. The takeaway: ask for the per-gram or per-package price of your product, not a headline average.

Who gets funded treatment

Not everyone pays the full bill. Certain populations are entitled to funding or assistance, including work-accident victims, patients insured through the Ministry of Defence (notably disabled IDF veterans), and victims of hostile acts (Yad LaOlim). For disabled veterans treated for PTSD — a group that has grown sharply since October 2023 — the Ministry of Defence funds treatment, which is one reason cannabis use among that population has risen so visibly. If you fall into one of these categories, confirm your entitlement before paying out of pocket, as the funding route differs from the standard HMO process.

Why prices may not stay where they are

Cannabis pricing in Israel is unusually exposed to policy fights. Because the country imports a large share of its flower, trade measures feed straight through to the pharmacy shelf. A proposed anti-dumping duty of up to 165% on Canadian imports was advanced and then rejected during 2024–25, but the episode showed how quickly patient prices could move if import policy shifts. Israeli media have repeatedly warned that medical cannabis prices risk climbing "too high" for patients if supply tightens (Times of Israel). For the regulatory backdrop, see our Regulation hub.

Practical tips for keeping costs down

Confirm pricing at more than one authorised pharmacy before you fill a prescription — because prices are not fixed, the same product can vary between outlets. Ask specifically about the product profile your licence allows, since switching between an oil and flower, or between THC/CBD categories, changes the price. Keep your renewal paperwork current to avoid gaps that force repeat consultation fees. And if you belong to a funded category, sort out that entitlement first — it can eliminate the largest line on the bill entirely.

For the wider picture on eligibility, products and the application process, start at our Patient Access hub, and see our companion guides on qualifying conditions and getting a licence.